Vivos Therapeutics Inc. (NASDAQ:VVOS) shares surged 21.21% after hours to $1.60 on Thursday after a Securities and Exchange Commission filing revealed that a Michigan-based investor group acquired a 19.9% stake through a $2.39 million private placement.
SP Manager LLC and its managing director, Michael C. Skaff, now control 19.9% of VVOS’s outstanding common stock, or roughly 2.69 million shares. Their stake is held through three affiliated investment vehicle: V-CO Investors LLC with 3.8%, V-CO Investors 2 LLC with 6.1%, and V-CO Investors 3 LLC with 10%.
SP Manager LLC often serves as a manager or advisor for specific investment vehicles and private ventures.
Convertible Promissory Note
On March 31, V-CO Investors 3 LLC entered a Securities Purchase Agreement with Vivos, acquiring …
